Aims: Our study aims to investigate the effect of microRNA-21 (miR-21) on the proliferation, senescence, and apoptosis of glioma cells by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.
available treatments such as surgery, radiotherapy, chemotherapy. 3 It is known that the inhibition of tumor suppressor genes leads to gene methylation which further represses accumulation and induces mutation, which plays a significant role in the development and progression of tumor, and glioma progression is caused by an accumulation of epigenetic and genetic alterations. 4 MicroRNAs (miRNAs) are a class of small noncoding RNAs, which function as significant post-transcription regulators of gene expression, and exert a further alteration of protein expressions. 5 Particularly, the abnormal expressions of miRNAs influence tumor development and progression including apoptosis, proliferation, differentiation as well as metabolism. 6 Recently, it has been reported that miRNAs are involved in the modulation of glioma development especially some upregulated miRNAs like microRNA-21 (miR-21), which has been demonstrated as an oncogene in cultured glioma cells and could be a novel chemotherapeutic target for the treatment of glioma. 7 According to a previous report, miR-21 was overexpressed in human glioma tissues and some cell lines, which was associated with increased proliferation, metastatic potential, decreased apoptosis, and was accountable for the rapid development and malignant progression of glioma, with a lot of miR-21 targets involved.
8
As a type of downstream target, Sprouty1 (SPRY1) has negative modulation of some signaling pathway like the FGF-Ras-ERK signaling. 9 According to a previous study, miR-21 was associated with SPRY1, phosphatase and tensin homolog (PTEN). 10 Notably, the phosphatidylinositol 3-kinase (PI3K)/AKT pathway with a direct downstream target of PTEN is closely related to some miRNAs like miR-519a and plays a crucial role in tumor progression. 11 PI3K is involved in several cellular processes, including cell proliferation, cell apoptosis, and differentiation. 12 Recent evidence revealed that the activation of AKT (serine-threoine kinase) plays a central role in glioma development as well as progression, and AKT is phosphorylated by the activation of PI3K, which then serves as a secondary messenger in the PI3K/PTEN signaling pathways. 13 However, there were few studies focusing on the mechanism of miR-21 targeting SPRY1
on cell growth in human glioma through the PTEN/PI3K/AKT signaling pathway. Thus, this study aims to investigate the mechanism by means of which miR-21 affects cell proliferation, cellular senescence, and apoptosis in glioma by targeting SPRY1 through the PTEN/PI3K/AKT signaling pathway.
| MATERIALS AND METHODS

| Ethics statement
This study was authorized by the Ethics Committee of Henan Provincial People's Hospital. Signed informed consents were obtained from all patients participating in the study.
| Study subjects
A total of 140 glioma samples were extracted from patients 
| Immunohistochemical staining
All brain tissues enrolled in this study were sliced into 4-μm sections.
Then, sections were routinely dewaxed and rehydrated. Subsequently, the sections were incubated with 3% hydrogen peroxide for 10 minutes to eliminate peroxidase activity. After washing with distilled water for 1 minute, the sections were rinsed in a PBS solution for 5 minutes.
Then, section was treated with high-temperature antigen retrieval by citrate buffer solution and cooled at room temperature. Subsequently, the sections were rinsed with phosphate buffer saline (PBS, AR003;
Boster Biological Technology Co., Ltd., Wuhan, Hubei, China) for 3 minutes, and the process was repeated 3 times. Next, the sections were incubated with 5% normal goat serum (diluted by PBS) at room temperature for 15 minutes and then the normal goat serum was removed. Primary antibody rabbit antihuman SPRY1 (diluted at a ratio of 1:200, HPA051369; Neobioscience Co., Ltd., Shenzhen, Guangdong, China) was added into sections until surface of tissues was completely covered. Then, the sections were stored at 4°C for 12 hour.
The following day, after rinsing with PBS 3 times (3 minutes per time), the sections were incubated with horseradish peroxidase-labeled 
| Reverse transcription quantitative polymerase chain reaction (RT-qPCR)
Total RNA in cells and tissues was extracted based on the instructions of RNA extraction kit (D203-01; Genstar Biosolutions Co., Ltd., 
| Western blotting
Glioma tissues and control brain tissues were collected and preserved with liquid nitrogen for further experimentation. The tissues were ground into fine powder using a mortar and pestle. Subsequently, centrifuged at 12 000 rpm at 4°C for 20 minutes. After the fat layer was removed, the supernatant was used to determine protein con- 
| Dual-luciferase reporter assay
The biological prediction website microRNA.org (http://www.mi- 
| Beta-galactosidase (β-Gal) staining
A total of 1 × 10 5 U87 cells in the logarithmic phase of growth were inoculated in a 12-well plate. When cell confluence reached 50%, the blank and NC groups were regarded as the control group, and the miR-21 mimics, miR-21 inhibitors, siRNA-SPRY1, and miR-21 inhibitors + siRNA-SPRY1 groups were regarded as the experimental group.
The cells were cultured for 48 hours and stained using β-Gal to detect the rate of cell senescence. After the cell culture medium was discarded, cells were rinsed with PBS and fixed with β-Gal for 15 minutes at room temperature. After discarding the cell-fixing solution, the cells were rinsed with PBS. Each well was added with 500 μL dyeing fluid, and the 6-well plate was sealed with a preservative film followed by incubation at 37°C for 12 hours. Subsequently, the staining solution was discarded, and the cells were observed and photographed under the light microscope. Senescence index (SI) = positive cell number of senescent cells/total cell number × 100%.
| 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
A total of 5000 U87 cells in the logarithmic phase of growth were inoculated in each well, and each group was repeated in 3 wells. Then, 
| Flow cytometry
After transfection for 24 hours, the cells without culture medium were rinsed with PBS and digested with 0.25% trypsin. After the digestive solution was removed, the cells were observed under a microscope.
When the cells shrunk in size and attained a circular shape, the culture medium with serum was added to terminate digestion. The cells were triturated to isolate them from the wall using a pipette, and subsequently, a mixed-cell suspension was made. Then, the cell suspension was centrifuged at 1000 rpm for 5 minutes, and then the supernatant and gently shaken. The cells were incubated for 15 minutes at room temperature and then 1 mL HEPES buffer was supplemented. FITC fluorescence was detected using a 520-nm band-pass filter, while PI was detected using a 610-nm band-pass filter with an excitation wavelength at 488 nm. Apoptosis index (AI) = apoptotic cell number/total cell number. 
| Statistical analysis
| RESULTS
| Expression levels of miR21 and SPRY1 mRNA are correlated with clinicopathological features of glioma patients
The expression levels of miR-21 and SPRY1 mRNA were correlated with tumor malignancy, tumor size, and infiltration depth in glioma pa- and SPRY1 mRNA had no correlation with gender, age, and tumor site of glioma patients (P > .05) ( Table 3 ).
| Positive expression SPRY1 protein in the control and glioma groups
Immunohistochemical results indicated that the SPRY1 protein was mainly expressed in the cytoplasm as brownish-yellow colored granules in the control group. The brownish-yellow granules in the cytoplasm of the control group were regarded as positive, while no evident brownyellow granule in the glioma group was regarded as negative ( Figure 1 ).
| mRNA levels of miR-21, SPRY1, PTEN, PI3K, and AKT in the control and glioma groups
The results of RT-qPCR ( Figure 2) showed that, compared with the control group, mRNA levels of miR-21, PI3K, and AKT increased in the glioma group, but mRNA levels of SPRY1 and PTEN decreased (all P < .05).
| Protein levels of SPRY1, PTEN, PI3K, AKT, p-AKT, Caspase-3, Caspase-9, P53, GSK3, and p-GSK3 in the control and glioma groups
The results of Western blotting ( Figure 3 ) revealed that there was an elevation in the protein levels of PI3K, AKT, p-AKT, P53, and p-GSK3 (P < .05), and a reduction in the protein levels of SPRY1, PTEN, Caspase-3, and Caspase-9 in the glioma group (P < .05), and no significant difference was found in protein level of GSK3 (P > .05) when compared to the control group.
| SPRY1 is the target gene of miR-21
According to the analysis conducted by an online bioinformatics website (http://www.microrna.org), SPRY1 was the targeted gene of miR- mimics, which was considered as the NC group. The results of the dual-luciferase reporter assay system indicated that there was a significant reduction in the luciferase signal in SPRY1-wt cotransfection group, compared with other miR-21 transfection groups (P < .05).
And, there was no difference in the luciferase signal of SPRY1-mut among miR-21 transfection groups (P > .05). Thus, it was concluded that SPRY1 was the target gene of miR-21 ( Figure 4 ) and miR-21 could negatively regulate mRNA level of SPRY1.
| mRNA levels of miR-21, PRY1, PTEN, PI3K, and AKT among different groups
After transfection for 48 hours, RT-qPCR was adopted to determine mRNA levels of cells in all groups ( Figure 5 ). Compared with the normal group, other groups exhibited an increased expression of miR-21
and increased mRNA expressions of PI3K and AKT, but decreased mRNA expressions of SPRY1 and PTEN (P < .05). In addition, compared with the blank and NC groups, miR-21 expression deceased in the miR-21 inhibitors + siRNA-SPRY1 group (P < .05), and there were no significant differences in the mRNA levels of SPRY1, PTEN, PI3K, and AKT (P > .05); in the miR-21 mimics group, miR-21 expression and mRNA expressions of PI3K and AKT increased while mRNA levels of SPRY1 and PTEN decreased (P < .05); there was no significant difference in miR-21 expression in the siRNA-SPRY1 group; and mRNA 
T A B L E 3 Correlations of miR-21 expression level and mRNA level of SPRY1 with clinicopathological features of glioma patients
| Down-regulated miR-21 expression inhibits human glioma U87 cell proliferation
MTT results indicated that, compared with the blank and NC groups, cell proliferation reduced in the miR-21 inhibitors group and increased in the miR-21 mimics and siRNA-SPRY1 group (P < .05); there were no significant differences in cell proliferation in the miR-21 inhibitors + siRNA-SPRY1 group (P > .05). There were no significant differences among the miR-21 mimics and siRNA-SPRY1 groups (P > .05) (Figure 8 ).
| Down-regulated miR-21 expression promotes human glioma U87 cell apoptosis
After transfection for 48 hours, flow cytometry was conducted for the detection of cell cycle and cell apoptosis. Compared with the blank and NC groups, a decrease in cell number was observed in the S phase and an increase in cell number was observed in the G0/G1 F I G U R E 1 Immunohistochemical staining of SPRY1 in the control and glioma groups (×200). A, immunohistochemical staining for SPRY1 in the control and glioma groups; B, the positive expression rate of SPRY1; *P < .05, compared with the control group; SPRY1, Sprouty1
Positive rate (%) There were no significant differences in cell number in miR-21 inhibitors + siRNA-SPRY1 groups (P > .05) ( Figure 9A-B) . According to the analysis of cell apoptosis by flow cytometry, the results indicated that, compared with the blank and NC groups, the number of apoptotic cells increased in the miR-21 inhibitors group (P < .05), and the number of apoptotic cell decreased in the miR-21 mimics and siRNA-SPRY1 groups (P < .05), and there were no significant changes in the miR-21 inhibitors + siRNA-SPRY1 group (P > .05).
The results (Figure 9C-D) revealed that inhibition of miR-21 expression can suppress U87 cell proliferation and promote its apoptosis in glioma.
| DISCUSSION
MicroRNA-21 plays a significant role in the occurrence and progression of tumors and the malignancy of various human cancers by targeting tumor-suppressing genes. 18, 19 Previously, miR-21 has been functionally demonstrated as an anti-apoptosis factor in glioblastomas. 20 Furthermore, the PTEN/PI3K/AKT signaling pathway plays a crucial role in cell growth, apoptosis, as well as proliferation in Wilms'
Tumor. 21 However, there are few studies focusing on the mechanism of the role of miR-21 in cell proliferation and apoptosis in glioma by targeting specific genes. 22 Therefore, the present study explored the expression of miR-21 in human glioma and its effect on the cell proliferation, senescence, and apoptosis by targeting SPRY1 through the PTEN/PI3K/AKT signaling pathway. Human glioma is the most common primary brain tumor and the prognosis is unfavorable despite of advancements in surgical intervention and treatment. 23 According to a previous report, miR-21 was considered as an oncomir with functional effects on the occurrence as well as progression of diverse caners, and their dysregulation, especially a dramatic upregulation, was closely related to uncontrolled proliferation, apoptosis, and invasiveness, which was recognized as a useful biomarker for clinical diagnosis. 24 A recent study revealed that there were increased levels of miR-21 in most human cancers and cell lines including glioblastoma tumors, thus signifying that miR-21 plays a significant role in the cell growth, proliferation, and apoptosis in glioblastoma. 22 Our results also found that miR-21 was highly expressed in the glioma group when compared with the control group. Thus, miR-21 might be associated with the development and progression of the malignancy of human glioma.
It was firstly identified that SPRY is an antagonist of fibroblast growth factor (FGF) and epidermal growth factor (EGF) signaling in a genetic screen in Drosophila. 25 In addition, sprouty protein was con- human glioma is required in the future to further improve the prognosis of glioma patients.
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